This appendix contains worked-out examples on how to anticipate and handle each pattern of missing reference standard data. These examples are loosely based on the studies listed in Table 1 . Diagrams depicting the patient flow through the study are found below this text.
Incidental missing data
In a study on the accuracy of rapid diagnostic tests (RDTs) for malaria in which the reference standard is expert microscopy, the reference standard was not performed on a small random group of patients because their blood samples were lost during transportation. In this situation, the researchers considered it safe to assume that these samples are incidentally missing and calculated the sensitivity and specificity only using participants for which the reference standard was available (a complete case analysis). In this situation, it is helpful to provide a flow chart to make clear to the reader which participants are missing a reference standard result. Researchers could also check to see whether the complete case analysis results fall within the test-ignorance-region (range of sensitivities and specificities possible if the missings are haphazard), to further strengthen their confidence that the missing reference standard results did not introduce a meaningful amount of bias.
Data missing by study design
In a screening study on the accuracy of visual inspection with acetic acid for detecting cervical cancer, the reference standard was colposcopy, with biopsy if indicated. Instead of having all 10,000 women undergo colposcopy, which was not financially feasible, or comfortable for the patients, the researchers decided to only to perform the reference standard if the a potential malignancy was seen during visual inspection and in a random 10% of the patients in which the visual inspection was normal. The plan was to use inverse probability weighting to infer what the reference standard results might have been had all participants been verified. Doing so would essentially distribute the 7,200 participants with a negative VIA who were did not receive colposcopy back into the 2x2 table according the proportions of diseased and no-diseased observed among the index test negatives.
However, what the researchers did not expect was that this design would not work in practice. Women with normal VIA results who were not selected for colposcopy sometimes had an abnormal PAP and were therefore referred for colposcopy anyway. Additionally, women who were assigned to receive colposcopy declined. In the analysis, a more complicated inverse probability weighting model in which PAP results were taken into account was used. However, multiple imputation would likely also have produced similar estimates of accuracy if PAP was included in the imputation model. If the reason for receiving the reference standard was thought to be influenced by more than VIA and PAP results, multiple imputation would likely produce estimates closer to the truth.
Data missing due to clinical practice
In a study on the accuracy of fecal calprotectin in children to screen for inflammatory bowel disease (IDB), the gold standard was endoscopy with biopsy. It was not considered ethical to perform this invasive reference standard in children unless the suspicion was very strong. Therefore the researchers decided to only perform the reference standard in children with at least one "red flag". These red flags are signs, symptoms, or test results that heighted physicians suspicion of IBD, but did not include the test under study, fecal calprotectin. The rest of the children were followed-up over a period of a year and if they developed a red flag, they were also referred for endoscopy. At the end of one year follow up, if there was no diagnosis made, they were considered to have no IBD.
In this situation there are several possible analytical approaches. If follow-up is thought to be sensitive enough to pick up all cases, differential verification could be considered and the results could be analyzed by pooling all patients, regardless of whether they had endoscopy or only follow-up as the reference standard. However, if follow-up missed some cases, such results would likely be biased. Better options are multiple imputation (in which all patient characteristics are used to predict endoscopy results) or a Bayesian correction method (in which the prior beliefs on the accuracy of both endoscopy and follow-up are specified as well as the verification pattern are specified). It might be a wise idea to do both, and have one function as a sensitivity analysis to hopefully strengthen the findings. If choosing multiple imputation in the protocol phase of the study, researchers could have decided to collect additional test results that might improve imputation of the missing reference standard. If choosing a Bayesian correction method, they would need to search for information on accuracy of follow-up (which might be obtained, for example, from similar studies in adults or studies with longer follow-up).
Data missing due to infeasibility
Studies on imaging screening tests for cancer often run into the problem that the reference test, biopsy, can only be performed when a lesion is identified by the screening test. In a study on ultrasound to screen young women for breast cancer, biopsies are only taken when lesions are observed on ultrasound. In this scenario, the predictive values are unbiased and clinically interpretable. However, sensitivity and specificity, if calculated by combining the results from biopsy and follow-up may be biased. More information on the usefulness of ultrasound in clinical practice can be obtained from alternative study designs, for example, such as one which looks at the comparative accuracy to an alternative screening test such as mammography.
Eligible patients n=1000
Rapid diagnostic test (RDT) n=980
No index test n=20
RDT positive n=30
RDT negative n=950
No reference standard performed Blood sample lost n=2
No reference standard performed Blood sample lost n=20
Microscopy n=28
Microscopy n=930 
